4.7 Article

The deleterious effect of cholesterol and protection by quercetin on mitochondrial bioenergetics of pancreatic β-cells, glycemic control and inflammation: In vitro and in vivo studies.

期刊

REDOX BIOLOGY
卷 9, 期 -, 页码 229-243

出版社

ELSEVIER
DOI: 10.1016/j.redox.2016.08.007

关键词

Cholesterol; Glycemic control; Mitochondrial dysfunction; Quercetin; Sirtuin-1; NF kappa B

资金

  1. Fondecyt Initiation into Research Grant [11130232]
  2. IPRS
  3. UQCent scholarships from the University of Queensland
  4. MNDRIA Bill Gole Postdoctoral Research Fellowship
  5. University of Queensland
  6. NHMRC project grant [1044007]

向作者/读者索取更多资源

Studying rats fed high cholesterol diet and a pancreatic beta-cell line (Min6), we aimed to determine the mechanisms by which quercetin protects against cholesterol-induced pancreatic beta-cell dysfunction and impairments in glycemic control. Quercetin prevented the increase in total plasma cholesterol, but only partially prevented the high cholesterol diet-induced alterations in lipid profile. Quercetin prevented cholesterol-induced decreases in pancreatic ATP levels and mitochondrial bioenergetic dysfunction in Min6 cells, including decreases in mitochondrial membrane potentials and coupling efficiency in the mitochondrial respiration (basal and maximal oxygen consumption rate (OCR), ATP-linked OCR and reserve capacity). Quercetin protected against cholesterol-induced apoptosis of Min6 cells by inhibiting caspase-3 and -9 activation and cytochrome c release. Quercetin prevented the cholesterol-induced decrease in antioxidant defence enzymes from pancreas (cytosolic and mitochondrial homogenates) and Min6 cells and the cholesterol-induced increase of cellular and mitochondrial oxidative status and lipid peroxidation. Quercetin counteracted the cholesterol-induced activation of the NF kappa B pathway in the pancreas and Min6 cells, normalizing the expression of pro-inflammatory cytokines. Quercetin inhibited the cholesterol-induced decrease in sirtuin 1 expression in the pancreas and pancreatic beta-cells. Taken together, the anti-apoptotic, antioxidant and anti-inflammatory properties of quercetin, and its ability to protect and improve mitochondrial bioenergetic function are likely to contribute to its protective action against cholesterol-induced pancreatic beta-cell dysfunction, thereby preserving glucose-stimulated insulin secretion (GSIS) and glycemic control. Specifically, the improvement of ATP-linked OCR and the reserve capacity are important mechanisms for protection of quercetin. In addition, the inhibition of the NF kappa B pathway is an important mechanism for the protection of quercetin against cytokine mediated cholesterol-induced glycemic control impairment. In summary, our data highlight cellular, molecular and bioenergetic mechanisms underlying quercetin's protective effects on beta-cells in vitro and in vivo, and provide a scientifically tested foundation upon which quercetin can be developed as a nutraceutical to preserve beta-cell function. (C) 2016 The Authors. Published by Elsevier B.V.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Food Science & Technology

Beneficial Effects of Bioactive Compounds Obtained from Agro-Industrial By-Products on Obesity and Metabolic Syndrome Components

Nicolas Jeria, Sebastian Cornejo, Gabriel Prado, Andres Bustamante, Diego F. Garcia-Diaz, Paula Jimenez, Rodrigo Valenzuela, Carlos Poblete-Aro, Francisca Echeverria

Summary: The generation of agro-industrial by-products is a problem in terms of economics and the environment, but these materials can be a valuable source of bioactive compounds for various purposes. With the increasing prevalence of obesity and metabolic syndrome, there is a constant need for new strategies to prevent and treat these conditions. Revalorization of agro-industrial by-products for functional foods and nutraceutical development is gaining importance.

FOOD REVIEWS INTERNATIONAL (2023)

Article Clinical Neurology

Patient perspectives on digital healthcare technology in care and clinical trials for motor neuron disease: an international survey

Jochem Helleman, Barbara Johnson, Cory Holdom, Esther Hobson, Deirdre Murray, Frederik J. Steyn, Shyuan T. Ngo, Anjali Henders, Madhura B. Lokeshappa, Johanna M. A. Visser-Meily, Leonard H. van den Berg, Orla Hardiman, Anita Beelen, Chris McDermott, Ruben P. A. van Eijk

Summary: This study investigated the attitude and preferences of patients with motor neuron disease (MND) towards remote monitoring and the use of digital technology. The results showed that the majority of patients were positive about self-monitoring their health from home and being remotely monitored by a multidisciplinary care team. They were also willing to participate in clinical trials from home. However, some patients expressed concerns about the burden and distress of home-monitoring, as well as privacy and data security. Addressing these concerns is important for the widespread adoption of remote digital technology in clinical MND care.

JOURNAL OF NEUROLOGY (2022)

Review Biochemistry & Molecular Biology

Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis

Leanne Jiang, Shyuan T. Ngo

Summary: Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neuromuscular disorder with no cure available. TDP-43, a protein found in more than 97% of ALS patients, is believed to play a crucial role in the disease process. Targeting TDP-43 could be a promising approach for future therapeutic investigations.

METABOLITES (2022)

Review Biochemistry & Molecular Biology

Targeting Mitochondria for the Prevention and Treatment of Nonalcoholic Fatty Liver Disease: Polyphenols as a Non-pharmacological Approach

Jaime Zapata, Mauricio Castro-Sepulveda, Sandra Soto-Alarcon, Daniela Alvarez, Andres Bustamante, Guiselle Villarroel, Arturo Gallardo, Diego Fernando Garcia-Diaz, Rodrigo Valenzuela, Francisca Echeverria

Summary: Nonalcoholic fatty liver disease (NAFLD) has a high and growing prevalence globally. Mitochondria play a crucial role in regulating cell energy homeostasis, but their control mechanisms can be disrupted in the context of energy overload. Damaged mitochondria worsen NAFLD progression. Diet and lifestyle changes are the main recommendations for NAFLD prevention and treatment. Some polyphenols have shown promising effects in improving mitochondrial function in NAFLD and obesity models.

CURRENT MEDICINAL CHEMISTRY (2023)

Review Clinical Neurology

Potential new roles for glycogen in epilepsy

Gerald A. Dienel, Lisa Gillinder, Aileen McGonigal, Karin Borges

Summary: Seizures often originate in epileptogenic foci. Between seizures (interictally), the foci and surrounding tissue often have low signals in FDG-PET, indicating glucose hypometabolism. Normal glucose but high glycogen levels have been found in epileptogenic brain areas during the interictal period. Glycogenolysis may lead to low FDG signals and contribute to seizure generation.

EPILEPSIA (2023)

Article Clinical Neurology

Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis

Jeryn Chang, Thomas B. Shaw, Cory J. Holdom, Pamela A. McCombe, Robert D. Henderson, Jurgen Fripp, Markus Barth, Christine C. Guo, Shyuan T. Ngo, Frederik J. Steyn

Summary: This study found that lower hypothalamic volume is associated with lower and higher BMI in ALS patients, unlike AD patients and controls. Hypothalamic volume is not related to loss of appetite or hypermetabolism. In ALS patients, lower hypothalamic volume with lower BMI is associated with weight loss and earlier death.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Biochemistry & Molecular Biology

β-Hydroxybutyrate and Medium-Chain Fatty Acids are Metabolized by Different Cell Types in Mouse Cerebral Cortex Slices

Jens Andersen, Emil W. Westi, Elliott S. Neal, Blanca Aldana, Karin Borges

Summary: Ketogenic diets and medium-chain triglycerides play important roles in the treatment of neurological disorders, with their metabolites serving as auxiliary brain fuels in different cell types without notable competition.

NEUROCHEMICAL RESEARCH (2023)

Article Endocrinology & Metabolism

Vitamin B12 deficiency induces glucose intolerance, delays peak insulin levels and promotes ketogenesis in female rats

Elliott S. Neal, Vinod Kumar, Karin Borges, James S. M. Cuffe

Summary: Vitamin B-12 deficiency is common in individuals with diabetes mellitus, and it may contribute to impaired glucose homeostasis. In a study using rats, B-12 deficiency led to a prediabetic-like phenotype characterized by glucose intolerance and increased ketogenesis. The deficiency was associated with reduced liver anaplerosis, altered one-carbon metabolite levels, and decreased B vitamins in the liver, which likely contributed to deficits in glucose handling. These findings highlight the importance of adequate B-12 intake for metabolic health and suggest that B-12 deficiency may promote the development of metabolic disorders like diabetes mellitus.

JOURNAL OF ENDOCRINOLOGY (2023)

Article Clinical Neurology

Use of hip- versus wrist-based actigraphy for assessing functional decline and disease progression in patients with motor neuron disease

Cory J. Holdom, Jordi W. J. van Unnik, Ruben P. A. van Eijk, Leonard H. van den Berg, Robert D. Henderson, Shyuan T. Ngo, Frederik J. Steyn

Summary: This study examined the use of wrist and hip accelerometers to measure activity levels in patients with Motor Neuron Disease (MND) compared to controls. The results showed that wrist-based measurements were more variable and had differing sensitivity to specific functional outcomes compared to hip-based measurements. Careful selection of measurement devices and analysis methods is necessary for at-home monitoring of disease progression in patients with MND.

JOURNAL OF NEUROLOGY (2023)

Review Clinical Neurology

Skeletal muscle in amyotrophic lateral sclerosis

Jeremy M. Shefner, Antonio Musaro, Shyuan T. Ngo, Christian Lunetta, Frederik J. Steyn, Richard Robitaille, Mamede De Carvalho, Seward Rutkove, Albert C. Ludolph, Luc Dupuis

Summary: Amyotrophic lateral sclerosis (ALS), a major motor neuron disease, has long been considered as primarily affecting motor neurons and neuromuscular junctions, with muscle changes being secondary. However, recent studies have shown that skeletal muscle dysfunction might contribute to muscle weakness, as well as the degeneration of neuromuscular junctions and motor neurons in ALS. This article explores the various potential roles of skeletal muscle in ALS pathophysiology and compares ALS to other motor neuron diseases, providing insights for future research and treatment.
Review Biochemistry & Molecular Biology

Metabolic aspects of genetic ion channel epilepsies

Elliott S. Neal, Weizhi Xu, Karin Borges

Summary: Recent research has identified individual mutations in people with genetic epilepsies, leading to the development of genetic therapies. However, medication-resistant epilepsies still require alternative treatments, such as the ketogenic diet. The metabolic basis of ion channel epilepsies and their response to dietary therapies need further investigation.

JOURNAL OF NEUROCHEMISTRY (2023)

Review Clinical Neurology

Nutritional and metabolic factors in amyotrophic lateral sclerosis

Albert Ludolph, Luc Dupuis, Edward Kasarskis, Frederik Steyn, Shyuan Ngo, Christopher McDermott

Summary: Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease with non-motor symptoms. Nutritional status and metabolic balance have been found to contribute to faster disease progression and earlier death. Cellular changes, including mitochondrial dysfunction, are also shown to contribute to bioenergetic failure in ALS. Modifying energy balance in ALS shows potential as a treatment option and multiple clinical trials are underway.

NATURE REVIEWS NEUROLOGY (2023)

Article Cell & Tissue Engineering

p Generation of a human induced pluripotent stem cell line (UQi001-A-1) edited with the CRISPR-Cas9 system to carry the heterozygous TARDBP c.1144G > A (p.A382T) missense mutation

Timothy J. Tracey, Leanne Jiang, Melinder K. Gill, Samara N. Ranie, Dmitry A. Ovchinnikov, Ernst J. Wolvetang, Shyuan T. Ngo

Summary: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease, and the TDP-43 protein plays a crucial role in its pathophysiology. This study used the CRISPR-Cas9 system to introduce a heterozygous missense mutation (c.1144G > A, p.A382T) in exon 6 of the TARDBP gene into iPSCs derived from a healthy individual. The edited iPSCs maintained normal cellular morphology, pluripotency markers expression, tri-lineage differentiation ability, and karyotype.

STEM CELL RESEARCH (2023)

Article Nutrition & Dietetics

Effects on Fetal Metabolic Programming and Endocannabinoid System of a Normocaloric Diet during Pregnancy and Lactation of Female Mice with Pregestational Obesity

Cynthia Barrera, Valeska Castillo, Rodrigo Valenzuela, Carina A. Valenzuela, Diego F. Garcia-Diaz, Miguel Llanos

Summary: This study aimed to determine the effects of a nutritional intervention during pregnancy and lactation on metabolic alterations of obese female progenitors' offspring and on the involvement of the endocannabinoid system (ECS). The results showed that the intervention normalized some hormonal parameters and hepatic mRNA levels of ECS components, improving the condition of the obese offspring.

NUTRIENTS (2023)

Article Food Science & Technology

Glycolytic Effect of Meat Metabolites: Role of Dietary Compounds and Their Microbiota-Derived Metabolites in the Prevention of Lung Cancer Development

Catalina Carrasco-Pozo, Vicky M. Avery

Summary: The study aimed to investigate the role of dietary components and their microbiota-derived metabolites in the initiation of lung cancer. Natural compounds and metabolites, such as sulforaphane, apigenin, quercetin, and gallic acid, were found to reduce cell viability and glycolysis in early-stage lung cancer cells. Moreover, sulforaphane and quercetin metabolite, 3,4-dihydroxyphenylacetic acid, completely prevented the increase in glycolysis induced by hemin and PhIP in early-stage lung cancer cells.

ACS FOOD SCIENCE & TECHNOLOGY (2023)

暂无数据